OTC:AKBLF ALK-Abelló A/S (AKBLF) Stock Price, News & Analysis $21.68 -0.32 (-1.45%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$21.68▼$21.6850-Day Range$20.30▼$22.5052-Week Range$10.95▼$23.00Volume40 shsAverage Volume796 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartHeadlinesStock AnalysisAnalyst ForecastsChartHeadlines Get ALK-Abelló A/S alerts: Email Address Ad Colonial MetalsCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Russia, China and India have decided to abandon the petrodollar.In answer to this issue, we have released a Special Report to the public. About ALK-Abelló A/S Stock (OTC:AKBLF)ALK-Abelló A/S operates as an allergy solutions company in Europe, North America, and internationally. Its product portfolio includes GRAZAX/GRASTEK, RAGWITEK/RAGWIZAX, ACARIZAX/ODACTRA, MITICURE, CEDARCURE, and ITULAZAX/ITULATEK for treatment of allergic rhinitis and allergic asthma. The company offers allergy immunotherapy products in the form of injections, sublingual drops, and tablets for the treatment of various allergies, including grass, ragweed, house dust mite, Japanese cedar, tree, and food. It also provides consumer healthcare solution, which include Digital eco-system, a platform which connect and engages with allergy sufferers in the disease journey through tools and e-commerce offerings that supports, guidance and relief, and smoothing the path to allergy immunotherapy treatment. In addition, the company offers diagnostic allergy solutions through testing by skin prick test or blood test; and emergency treatment, such as intra-muscular injection of adrenaline for the treatment of acute life-threatening allergic reactions, including Anaphylaxis. The company has a collaboration with Torii Pharmaceutical Co., Ltd. to develop, market and distribute allergy immunotherapy tablet for the treatment of grass pollen allergy. ALK-Abelló A/S was founded in 1923 and is headquartered in Horsholm, Denmark.Read More AKBLF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart AKBLF Stock News HeadlinesJuly 27 at 2:56 AM | americanbankingnews.comALK-Abelló A/S (OTC:AKBLF) Trading Down 1.5%May 29, 2024 | finance.yahoo.comListen in on ALK’s Capital Markets Day on 4 June 2024July 27, 2024 | DTI (Ad)Heard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…May 3, 2024 | finanznachrichten.deALK Abello: ALK upgrades its full-year revenue outlookMay 2, 2024 | finance.yahoo.comThree-month interim report (Q1) 2024 (unaudited)May 2, 2024 | markets.businessinsider.comAlk-Abello A-S Bearer and-or registered B is about to announce its earnings — here's what Wall Street expectsMay 2, 2024 | finance.yahoo.comALK upgrades its full-year revenue outlookApril 24, 2024 | finance.yahoo.comInvitation to the presentation of ALK’s first quarter results on Friday 3 May 2024July 27, 2024 | DTI (Ad)Heard about the 72-Hour Profit Surge? Read this…One of the most overlooked opportunities in the stock market is the 72-Hour Profit Surge... A short period of time where we can bet on a stock that is ALREADY “winning.” Let me give you a perfect example of how the Surge worked with Ross Stores. Back on November 16th, a little move was made that sent their stock soaring… The next day, my system would have alerted me that Ross Stores had entered the 72-Hour Profit Surge…April 18, 2024 | benzinga.comAlaska Air Gr Stock (NYSE:ALK), Quotes and News SummaryMarch 27, 2024 | finance.yahoo.comSave the date for ALK’s Capital Markets Day on 4 June 2024March 14, 2024 | finance.yahoo.comAnnual General Meeting in ALK-Abelló A/S held on 14 March 2024February 16, 2024 | finance.yahoo.comAnnual General Meeting in ALK-Abelló A/S on 14 March 2024February 8, 2024 | finanznachrichten.deALK Abello: Annual report 2023: ALK delivers 9% sales growth with profits up 50%February 8, 2024 | finanznachrichten.deALK Abello: ALK and McMaster researchers discover new cell that remembers allergiesFebruary 8, 2024 | finance.yahoo.comAnnual report 2023: ALK delivers 9% sales growth with profits up 50%February 7, 2024 | finance.yahoo.comALK and McMaster researchers discover new cell that remembers allergiesFebruary 5, 2024 | finance.yahoo.comALK’s 2030 CO2 reduction targets have been approved by SBTiSee More Headlines Receive AKBLF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for ALK-Abelló A/S and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTC SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolOTC:AKBLF CUSIPN/A CIKN/A Webwww.alk.net Phone45.45.74.75.76FaxN/AEmployees2,824Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Reduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Click the link below to learn more about using beta to protect yourself.Get This Free Report Key ExecutivesMr. Claus Steensen Solje (Age 52)Executive VP, CFO & Member of Management Board Comp: $2.03MMr. Søren Daniel Niegel (Age 53)Executive VP of Commercial Operations & Member of Management Board Comp: $766.2kDr. Henriette Mersebach (Age 53)Executive VP Research & Development & Member of Management Board Comp: $886.3kMs. Katja Barnkob Thalund (Age 55)Project Director of Global CMC Development & Employee-elected Director Comp: $50.34kMr. Peter Halling (Age 47)President & CEO Mr. Per PlotnikofVP of Corporate Communications, Investor Relations & Strategic Planning and Head of IRProf. Hendrik Kees Kam Nolte M.D.Ph.D., Senior Vice President of Research & Development - North America and International MarketsMr. Christian G. HoughtonHead of Product SupplyMore ExecutivesKey Competitors180 Life SciencesNASDAQ:ATNFW3SBioOTCMKTS:TRSBF60 Degrees PharmaceuticalsNASDAQ:SXTPWAbcamOTCMKTS:ABCZFAdociaOTCMKTS:ADOIFView All Competitors AKBLF Stock Analysis - Frequently Asked Questions How have AKBLF shares performed this year? ALK-Abelló A/S's stock was trading at $13.25 at the beginning of 2024. Since then, AKBLF stock has increased by 63.6% and is now trading at $21.68. View the best growth stocks for 2024 here. How do I buy shares of ALK-Abelló A/S? Shares of AKBLF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTC:AKBLF) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredJ.P. Morgan’s DIRE WarningWhen the largest bank in the U.S. says a crisis is coming - you NEED to listen. The Wall Street Journal war...Behind the Markets | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredGrab a pen and write down this ticker - here's whyA megatrend now poised to mint a brand-new wave of millionaires right here in America. And today, self-made...StocksToTrade | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ALK-Abelló A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share ALK-Abelló A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
